Search research articles
Contact Us
Filters
Showing results (21-30 of 188) with videos related to
Page
of 19
Sort By:
Journal of Surgical Oncology
|
October 28, 2015
Hepatic hemorrhage as a consequence of rapid response to combined targeted therapy in metastatic melanoma
Devin C Flaherty, Brianna W Hoffner, Briana J Lau, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
|
September 27, 2018
Systemic therapy for relapsed/refractory meningioma: Is there potential for antiangiogenic agents?
Constantin A Dasanu, Yazeed Samara, Ion Codreanu, et al.
Cancer Immunology, Immunotherapy : CII
|
March 3, 2012
Assessment of association between BRAF-V600E mutation status in melanomas and clinical response to ipilimumab
Vafa Shahabi, Gena Whitney, Omid Hamid, et al.
American Journal of Clinical Oncology
|
January 24, 2015
Phase II study of nab-paclitaxel and bevacizumab as first-line therapy for patients with unresectable stage III and IV melanoma
Lynn E Spitler, Peter Boasberg, Steven O'Day, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 21, 2012
Sunitinib therapy for melanoma patients with KIT mutations
David R Minor, Mohammed Kashani-Sabet, Maria Garrido, et al.
Clinical Advances in Hematology & Oncology : H&O
|
April 9, 2016
Programmed death 1 immune checkpoint inhibitors
Meghna S Trivedi, Brianna Hoffner, Jennifer L Winkelmann, et al.
Journal of Translational Medicine
|
April 19, 2018
The Great Debate at "Melanoma Bridge", Napoli, December 2nd, 2017
Paolo A Ascierto, Corrado Caracò, Jeffrey E Gershenwald, et al.
Frontiers in Medicine
|
December 26, 2022
Case report: Later onset of NRAS-mutant metastatic melanoma in a patient with a partially-excised giant congenital melanocytic nevus
Bruno Almeida Costa, Victor Zibara, Vasundhara Singh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 4, 2007
Alum with interleukin-12 augments immunity to a melanoma peptide vaccine: correlation with time to relapse in patients with resected high-risk disease
Omid Hamid, Jolie C Solomon, Ronald Scotland, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
December 2, 2011
Ipilimumab increases activated T cells and enhances humoral immunity in patients with advanced melanoma
Jeffrey S Weber, Omid Hamid, Scott D Chasalow, et al.
Page
of 19
Search research articles
Search
Showing results (21-30 of 188) with videos related to
Sort By:
Page
of 19
Journal of Surgical Oncology
|
October 28, 2015
Hepatic hemorrhage as a consequence of rapid response to combined targeted therapy in metastatic melanoma
Devin C Flaherty, Brianna W Hoffner, Briana J Lau, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
|
September 27, 2018
Systemic therapy for relapsed/refractory meningioma: Is there potential for antiangiogenic agents?
Constantin A Dasanu, Yazeed Samara, Ion Codreanu, et al.
Cancer Immunology, Immunotherapy : CII
|
March 3, 2012
Assessment of association between BRAF-V600E mutation status in melanomas and clinical response to ipilimumab
Vafa Shahabi, Gena Whitney, Omid Hamid, et al.
American Journal of Clinical Oncology
|
January 24, 2015
Phase II study of nab-paclitaxel and bevacizumab as first-line therapy for patients with unresectable stage III and IV melanoma
Lynn E Spitler, Peter Boasberg, Steven O'Day, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 21, 2012
Sunitinib therapy for melanoma patients with KIT mutations
David R Minor, Mohammed Kashani-Sabet, Maria Garrido, et al.
Clinical Advances in Hematology & Oncology : H&O
|
April 9, 2016
Programmed death 1 immune checkpoint inhibitors
Meghna S Trivedi, Brianna Hoffner, Jennifer L Winkelmann, et al.
Journal of Translational Medicine
|
April 19, 2018
The Great Debate at "Melanoma Bridge", Napoli, December 2nd, 2017
Paolo A Ascierto, Corrado Caracò, Jeffrey E Gershenwald, et al.
Frontiers in Medicine
|
December 26, 2022
Case report: Later onset of NRAS-mutant metastatic melanoma in a patient with a partially-excised giant congenital melanocytic nevus
Bruno Almeida Costa, Victor Zibara, Vasundhara Singh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 4, 2007
Alum with interleukin-12 augments immunity to a melanoma peptide vaccine: correlation with time to relapse in patients with resected high-risk disease
Omid Hamid, Jolie C Solomon, Ronald Scotland, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
December 2, 2011
Ipilimumab increases activated T cells and enhances humoral immunity in patients with advanced melanoma
Jeffrey S Weber, Omid Hamid, Scott D Chasalow, et al.
Page
of 19